Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Antimicrobial Agents and Chemotherapy|May 23, 2023
Phase I Single Ascending Dose and Food Effect Study in Healthy Adults and Phase I/IIa Multiple Ascending Dose Study in Patients with Pulmonary Tuberculosis to Assess Pharmacokinetics, Bactericidal Activity, Tolerability, and Safety of OPC-167832Rodney Dawson, Andreas H Diacon, Kim Narunsky, et al.Antimicrobial Agents and Chemotherapy|January 29, 2020
Fourteen-Day Bactericidal Activity, Safety, and Pharmacokinetics of Linezolid in Adults with Drug-Sensitive Pulmonary TuberculosisAndreas H Diacon, Veronique R De Jager, Rodney Dawson, et al.American Journal of Respiratory and Critical Care Medicine|March 21, 2025
Telacebec, A Potent Agent in the Fight Against Tuberculosis: Findings from A Randomized, Phase 2 Clinical Trial and BeyondSaskia Janssen, Caryn Upton, Veronique R de Jager, et al.British Journal of Clinical Pharmacology|June 29, 2018
Relative bioavailability of bedaquiline tablets suspended in water: Implications for dosing in childrenElin M Svensson, Jeannine du Bois, Rene Kitshoff, et al.CPT: Pharmacometrics & Systems Pharmacology|August 8, 2026
Modeling Treatment Response in Tuberculosis Early Bactericidal Activity TrialsMairi C W McClean, Simon E Koele, Julia Dreisbach, et al.The Journal of Antimicrobial Chemotherapy|March 28, 2025
Population pharmacokinetics and exposure-response relationship of the antituberculosis drug BTZ-043Simon E Koele, Norbert Heinrich, Veronique R De Jager, et al.Science Translational Medicine|February 4, 2021
Fourteen-day PET/CT imaging to monitor drug combination activity in treated individuals with tuberculosisYingda L Xie, Veronique R de Jager, Ray Y Chen, et al.Pageof 1